Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Classificação em ações #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Preço da ação
$0.01292666
Última sincronização: 2025-04-08
Valor de mercado
$157.54K
Variação (1 dia)
6.84%
Variação (1 ano)
0.00%
País
GB
Negociar Synairgen plc (SNG)

Categoria

Lucros da Synairgen plc (SNG)
Lucros em Jun 2024 TTM: $-4.64M
De acordo com os últimos relatórios financeiros da Synairgen plc, os ganhos atuais da empresa são de $-4.64M. Em 2022, a empresa teve ganhos de $-24.31M, um aumento em relação a aos ganhos de 2021, que foram de $-78.22M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Synairgen plc de 2004 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-4.64M -62.26%
2023 $-12.29M -49.43%
2022 $-24.31M -68.92%
2021 $-78.22M 222.66%
2020 $-24.24M 281.43%
2019 $-6.36M 121,729.64%
2018 $-5.22K -336.99%
2017 $2.20K -100.05%
2016 $-4.20M 111,307.18%
2015 $-3.77K -315.15%
2014 $1.75K -100.05%
2013 $-3.75M -6.03%
2012 $-4.00M -32.03%
2011 $-5.88M 34.57%
2010 $-4.37M -6.90%
2009 $-4.69M -4.50%
2008 $-4.91M 29.79%
2007 $-3.78M 57.39%
2006 $-2.40M 119.97%
2005 $-1.09M 293.81%
2004 $-277.59K 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$5.27B -113,800.85%
US
$1.95B -42,146.41%
NL
- -
CH
- -
KR
$3.01B -64,888.45%
BE